10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2021 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 16, 2022) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
| Operating activities | |||
| Net Income | $ 6,095 | 4,572 | 4,807 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Net gains on financial instruments | (318) | (182) | (67) |
| Equity in net earnings of other invested assets | (562) | (51) | (93) |
| Depreciation and amortization | 1,302 | 1,154 | 1,133 |
| Deferred income taxes | 326 | (540) | 81 |
| Impairment of property and equipment | 73 | 198 | 0 |
| Share-based compensation | 255 | 283 | 294 |
| Changes in operating assets and liabilities: | |||
| Receivables, net | (2,138) | (256) | (1,053) |
| Other invested assets | (70) | (32) | (48) |
| Other assets | 37 | (283) | (170) |
| Policy liabilities | 2,597 | 3,528 | 1,826 |
| Unearned income | (113) | 202 | 115 |
| Accounts payable and other liabilities | 719 | 1,978 | (445) |
| Income taxes | 140 | 72 | (325) |
| Other, net | 21 | 45 | 6 |
| Net cash provided by operating activities | 8,364 | 10,688 | 6,061 |
| Investing activities | |||
| Purchases of investments | (18,669) | (19,492) | (22,954) |
| Proceeds from sale of investments | 10,269 | 11,318 | 18,598 |
| Maturities, calls and redemptions from investments | 4,344 | 4,741 | 2,437 |
| Changes in securities lending collateral | (956) | (849) | 254 |
| Purchases of subsidiaries, net of cash acquired | (3,476) | (1,976) | 0 |
| Purchases of property and equipment | (1,087) | (1,021) | (1,077) |
| Other, net | (63) | (45) | (50) |
| Net cash used in investing activities | (9,638) | (7,324) | (2,792) |
| Financing activities | |||
| Net proceeds from (repayments of) commercial paper borrowings | 50 | (150) | (297) |
| Proceeds from long-term borrowings | 3,462 | 2,484 | 2,473 |
| Repayments of long-term borrowings | (1,068) | (1,932) | (1,123) |
| Proceeds from short-term borrowings | 1,325 | 970 | 7,590 |
| Repayments of short-term borrowings | (1,050) | (1,670) | (8,035) |
| Changes in securities lending payable | 956 | 849 | (254) |
| Repurchase and retirement of common stock | (1,900) | (2,700) | (1,701) |
| Cash dividends | (1,104) | (954) | (818) |
| Proceeds from issuance of common stock under employee stock plans | 203 | 176 | 187 |
| Taxes paid through withholding of common stock under employee stock plans | (102) | (128) | (84) |
| Other, net | (349) | 488 | (204) |
| Net cash provided by (used in) financing activities | 423 | (2,567) | (2,266) |
| Effect of foreign exchange rates on cash and cash equivalents | (10) | 7 | 0 |
| Change in cash and cash equivalents | (861) | 804 | 1,003 |
| Cash and cash equivalents at beginning of year | 5,741 | 4,937 | |
| Cash and cash equivalents at end of year | 4,880 | 5,741 | 4,937 |
| External Links | |
| ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2021 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |